Après l’interdiction faite aux développeurs exploitant HealthKit pour leurs applis de partager les données collectées, Apple précise à présent que les logiciels stockant les données de santé sur iCloud seront interdits d’App Store.
Pendant des décennies, l’industrie pharmaceutique a délaissé les maladies rares et orphelines. Mais face aux génériques et à l’expiration de leurs brevets, les grands «labos» y investissent désormais des milliards de dollars pour assurer leurs profits et des relais de croissance.
Approximately one of every three Americans is older than 50, and they're remaining active and living longer. Meanwhile, roughly one in every 10 Americans owns an activity or sleep tracker – while seven out of 10 know what they are. But only one of every four people using an activity or sleep tracker is a senior.
Any guesses as to where the market might be heading?
A new report from the AARP cites the "great promise" that activity trackers hold for the senior market – for which health monitoring is and will continue to be essential. "The quality of their years is just as important as the quantity," the report notes, "and they are searching for tools to help them stay healthy and productive as they age – specifically tools that monitor progress toward wellness goals (steps, distance or elevation walked, for instance) and alert them to negative health developments (such as abnormal glucose or heart rate readings)."
A group of scientists and HCPs have published a paper indicating that, through their use of hashtags during medical society conferences, biopharmas and medical device companies exert a disproportionate influence on healthcare providers to promote their products or services instead of sharing unbiased, evidence-based information.
I must admit this aspect of pharma’s Twitter contributions to hashtags is one that I had not fully considered, possibly because I have been far more concerned with encouraging the industry to use social media and engage with HCPs openly. We should not forget that it was only a few years ago that the very first pharmas plucked up sufficient courage and developed appropriate internal guidelines to enable them to contribute to conference hashtags; Boehringer Ingelheim springs instantly to mind.
Yet, most importantly, the analysis raises some critical issues concerning the industry’s apparent power to influence: should its behaviour be curbed or regulated in some way?
Over the past 25 years, almost every industry has been transformed by technology, data, design and collaborative platforms that have made it easier for entrepreneurs and creators to develop and deliver solutions that once lived on the pages of...
Ce fil conducteur permet donc de relier les 7 grands métiers que nous avons recréés pour vous, afin de vous donner les moyens de transformer votre entreprise en un nouveau monde d'efficacité, adapté à la société moderne, hors du stress, et dans les valeurs de Respect mutuel, de Reconnaissance, de Sincérité et d'Epanouissement de chacun, pour une image clients d'excellence.
We are in the midst of the digital health movement, it's the topic taking up columns of media space, seminars across cities are headlining the topic and digital health start up investments during Q1 have already surpassed $600m in the US alone. As we witnessed the media frenzy regarding the Apple watch launch and its range of health applications, we now eagerly wait to see if the health revolution is really upon us and whether we will see a real shift in power from physician to patient?
Furthermore, what will this mean for pharma? Will a new patient segment emerge that is truly in control of their healthcare decisions, selling their health data to eagerly waiting research agencies and driving payer treatment decisions? Will chronic health patients finally have a support mechanism through digital technology which informs and helps them on a daily basis?
The truth is, we just don't know, it is likely the above scenario is some time away but one thing we do know is that primary care physicians are concerned with what this new digitally empowered patient segment will bring. The healthcare systems across Europe are already feeling the burden of patient numbers and whilst physicians acknowledge this shift, it is difficult to say whether digital health will bring more help or harm to the current patient–physician paradigm.
Tracking the physician perspective The Ipsos Healthcare Digital Doctor tracker aims to keep abreast of the physician activity and perception on digital health. Our data shows physicians across Europe are comfortable using the conventional technology options such as websites (61% visited a non-pharma and 46% a pharma website to obtain information on a specific drug) and online discussion forums (32% recommended these to their patients, and 34% use these platforms themselves to discuss with other HCPs). However, we are not yet seeing a strong engagement with new technologies such as app based services, with only 26% recommending a health and lifestyle app to a patient during consultation.
Physicians are in agreement health and lifestyle apps will play a strong role in the future, with a possibility they will form part of treatment plans for certain health conditions (57%). Conversely a similar proportion of physicians also believe apps will cause more conflict between themselves and patients (48%). This is where the complexity lays, whilst many are excited about the digital health revolution, healthcare professionals are troubled by the potential areas of conflict that will occur. There is a reluctance to fully embrace this new world and to push patients in the direction of digital health technologies.
How can the gap be met? Interestingly, conflict has always driven curious minds to the path of innovation; there is little doubt somebody (most likely a non-healthcare company) will bridge the gap and find a solution which enables the patient-physician consultation rather than hamper it. So, what will the ultimate solution be and what are the challenges which need to be overcome?
In order to truly engage physicians and empower patients, digital health solutions will need simplicity at the heart of them; there will need to be absolute confidence that the data is accurate and agreements are in place for data to be integrated with electronic medical records.
For pharma and healthcare providers this is an opportunity to support innovation at the grassroots level, through engaging with start-ups and non-traditional partners, thus allowing providers to play a role in shaping the future of digital health solutions. Providers need to be positive catalysts in this time of change, it is important they use their experience and knowledge to foster the patient-physician relationship and have an openness to walk the road less travelled. After all, without deviation from the norm, progress is impossible.
The app will be run on Samsung Galaxy S3 Mini phones, given to participants just for the study, and stripped of most other functionality. This will help to facilitate smartphone use in the elderly patient population. Patients will do six 30-second active tests a day on the app, as well as passive monitoring. The six tests consist of a voice test (saying “aaah” for as long as possible), a balance test (standing still), a gait test (walking 20 yards and turning around), a dexterity test (tapping buttons on the touch screen), a rest tremor test (holding the smartphone and counting down from 100), and a postural tremor test (the same as the rest test, but with the hand outstretched).
Investigators will keep watch on a dashboard to make sure each patient does their tests, and will be able to reach out to patients who neglect to do the active tests. The data collected will help investigators gauge the effectiveness of the treatment.
En juin, le chiffre d’affaires du marché remboursable affiche une évolution positive de 2,4%.
Cette augmentation est fortement imputable aux 2 jours ouvrés supplémentaires que comprend le mois de juin 2015 par rapport au même mois de l’année 2014.
Hors effet jours ouvrés, le marché remboursable aurait affiché une involution de -6,1%. En Cumul Fixe, le marché est en décroissance (-1,2%).
Depuis le début de l’année, le Répertoire des génériques n’a pas été impacté par la tombée dans le domaine public de molécules à fort potentiel.
L’évolution des médicaments du Répertoire est de -7,4% en chiffre d’affaires : -15,1% pour les princeps et -3,9% pour les génériques.
Le taux de pénétration des génériques a gagné 2 points en 6 mois : 76,0% en janvier et 78,1% en juin.
La croissance du marché hospitalier total poursuit son ralentissement avec une évolution au mois de juin de +5,0% en prix tarif.
Si on corrige de l’effet jours ouvrés, le marché aurait même été en involution (-3,7%).
Les médicaments rétrocédables et hors GHS évoluent de +1,8% en prix JO.
Pour la première fois depuis des mois, les médicaments « Rétrocédables autres », qui comprennent les produits en ATU et en post-ATU, affichent une évolution négative (-6,1%) liée à la fin de l’effet « bosse » des produits VHC.
I WOKE UP with a vague sense of dread on Sunday. I’d been on vacation for two weeks, my life totally, blissfully on pause. But I was back, and felt … well, I’m not exactly sure. Anxious? Overwhelmed? Maybe I was just hungry.Normally I would push those feelings aside and go about my day. Classic repression. But I’d recently been given Moodnotes, an app that asks you to record your emotions using the simplest of interfaces: A digital face. And so I gave, let’s call him Mr. Face, the deepest of frowns. The background turned slate grey to match my mood, and I clicked save.“What’s happening at the moment?” the app asked like a worried friend. I typed that I had just returned from vacation and was feeling uncertain about the week ahead. It prompted me to select my feelings (anxious, bored, guilty), then asked if I was falling into a “thinking trap,” therapist parlance for a knee-jerk way of reacting to certain situations.
Flexing your approach to online market research to engage patients who are be better connected both in the offline and digital world than expected.There’s a common misconception that the prospect of joining an online research community, for patients suffering with rare diseases, will be a unique enticing and exclusive opportunity for them. One assumes that they will be isolated and very eager to share their stories and to connect with individuals who’ve had similar experiences to them. We’ve of
KEY TAKEAWAY: 30% of social media users prefer social care to phoning customer service and this is happening across age groups and income brackets: 17% of people older than 55 prefer social media over the telephone for service, and nearly half of people earning more than $200k per year prefer social media over live interactions for customer service.
So how can pharma companies increase their ROI thru social media when the FDA has punted on social media marketing guidelines?
First, let’s remember that the most successful social media interactions are personal, genuine, and relevant. This means that pharma needs dedicated social media people who understand what they can and can’t do. It also means that taking some risk at the expense of engaging people who are tired of being seen as just another nameless patient.
According to Harvard Business Review the key steps to engaging people on social media are;
Gather and track the right information. Social media is in effect a massive focus group that can provide intelligence about brand perception, services, competitors, and potentially disruptive trends. It’s easy to be overwhelmed by it all, so companies should prioritize gathering social data that indicate trigger events. These signal the moment when patients are more open to, asking for or filling an Rx for your product.
Put in place processes to act on the insights. Some 72% of people who comment on a brand on Twitter expect an answer within an hour. Pharma has to develop guidelines for how to act when a particular event occurs. For example, someone asking about side effects for a particular drug could be directed to your safety page on your website while others questions can be answered within current FDA guidelines.
Measure your engagement. You can easily use web metrics to measure traffic from your social media interactions using specific URL’s or even coupons with special redemption codes.
Pharma DTC marketers cannot continue to talk TO patients they have to be willing to take some risk to engage them and help them choose treatments. Yes, there is a risk, but that risk can be managed by using people who understand social media and pharma guidelines.
Once again, social media proves its mettle among young people with health issues. Preliminary results of a study of asthmatic teenagers at Boston’s Partners HealthCare found significant improvement in engagement and in symptom control when patients received reminders and encouragement from clinicians and peers via Facebook.
Dr. Joseph Kvedar, vice president of connected health at Partners HealthCare, presented these early findings at the mHealth + Telehealth World conference in Boston this week. Kvedar told MedCity News that Partners is working on publication of the study in a peer-reviewed journal.
Partners Connected Health, formerly known as the Center for Connected Health, teamed up with the Department of Pulmonology at Massachusetts General Hospital and the pediatric asthma group at Partners Community HealthCare to create a private Facebook group for asthma patients aged 14-17. Partners paired the “secret” group, only viewable by invited users and not listed in Facebook search results, with a password-protected website called Connect 2 My ACT, where study participants could take the Asthma Control Test (ACT), a survey intended to measure asthma control.
La HAS publie un guide concernant les demandes de prise en charge dérogatoire d’un produit ou d’un acte innovant et met en ligne un espace dédié au forfait innovation. Cette démarche prolonge la loi de financement de la Sécurité Sociale 2015 qui entend rendre ce dispositif plus réactif. L’objectif est de faciliter un accès rapide des patients aux progrès de la médecine.
Aide au diagnostic et à la prescription, chirurgie robotique, télémédecine... Le numérique bouleverse la pratique médicale. Et c'est une bonne nouvelle : plus la machine entrera dans l'univers de la médecine, plus celle-ci sera humaine.
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.